The Valley Desk

NCT06685757 · Interventional trial

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Overall registry status Active not recruiting

Phase 3

Conditions Antibody-mediated Rejection

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov